The Readout LOUD Damian Garde, Meg Tirrell and Adam Feuerstein Listen: The next CRISPR fight, cheaper insulin, & an FDA shuffle
Pharmalot Ed Silverman STAT Plus: Pharmalittle: Eli Lilly cuts prices for some insulin products; congressional committee opens probe into PBMs
Pharmalot Matthew Herper and Ed Silverman Eli Lilly cuts prices for some insulin products, but some are wary
Health Matthew Herper One type of artificial sweetener may increase heart attack risk, preliminary study says
Pharmalot Ed Silverman STAT Plus: Pharmalittle: Biden wants $35 insulin cap for all Americans; pharma loses a court case over importing drugs from Canada
Health Elaine Chen STAT Plus: Mix-it-yourself Wegovy? Some are trying risky sources for weight-loss drugs
Biotech Jason Mast STAT Plus: After four years of big talk, mega startup Sana prepares to deliver some data
Pharmalot Ed Silverman STAT Plus: California is the latest state to sue drugmakers and PBMs over insulin pricing
First Opinion Robert Gabbay To effectively combat diabetes, policymakers must treat obesity like other diseases
The Readout LOUD Damian Garde, Allison DeAngelis and Adam Feuerstein The ‘electric vehicles’ of pharma, Illumina’s boondoggle, & a Theranos sentencing
Health Elaine Chen STAT Plus: Eli Lilly tightens access to diabetes drug, frustrating some people with obesity
Health Justin Chen STAT Plus: Nectar bats are ‘wonderful, majestic’ and sugar-obsessed. This researcher wants to know how they stay healthy
Pharmalot Ed Silverman STAT Plus: How many? A new analysis finds 1.3 million American adults rationed insulin due to cost
Pharmalot Ed Silverman STAT Plus: ‘Patchy efforts’ by major insulin makers mean access lags in many poor countries
Health Tech Katie Palmer STAT Plus: A bionic pancreas aims to take the math out of managing type 1 diabetes
Matt's Take Matthew Herper STAT Plus: The Senate’s drug pricing bill is an inevitable solution. It will still have plenty of unintended consequences
Politics Rachel Cohrs In a massive victory for Democrats, Medicare is poised to negotiate drug prices
Health Tech Katie Palmer STAT Plus: Patients seeking novel weight loss drugs find a ‘wild west’ of online prescribers
Health Edward Chen As diabetes during pregnancy grows more common, experts point to a need for preventive care
Health Akila Muthukumar Valliammai STAT Plus: Popular drug may have new benefit in men with diabetes, but not women, study shows
Health Tech Katie Palmer STAT Plus: With new research, health tech companies try to make a case for virtual diabetes care
Pharmalot Ed Silverman STAT Plus: Pharmalittle: Cancer coalition aims to boost access to meds in poor countries; Moderna’s vaccine patent defense poses shield for others
Biotech Matthew Herper STAT Plus: FDA approves Lilly diabetes drug that analysts expect to be a big seller
Health Isabella Cueto Black, Hispanic, and Asian Americans should be screened at lower BMI for diabetes, study says